GreenLight Metals (TSXV:GRL) Common Shares Approved for Trading on OTCQB

Medford, Wisconsin — January 12, 2026 — Leads & Copy — GreenLight Metals Inc. (TSXV: GRL) (OTCQB: GRLMF) has announced that its common shares have been approved for trading on the OTCQB® Venture Market in the United States under the symbol “GRLMF”. The Company’s common shares will continue to trade on the TSX Venture Exchange under the symbol “GRL”.

Matt Filgate, President & CEO, stated that trading on the OTCQB is an important milestone for GreenLight. Filgate added that GreenLight is focused on the United States, and this step increases the company’s visibility and accessibility with U.S. investors. The company believes it will help build a stronger U.S. investor following over time, broaden its shareholder base, and support long-term growth as it advances its portfolio and executes its U.S.-focused strategy. GreenLight expects to support this listing with enhanced investor outreach in the United States over the coming year.

The OTCQB is a U.S. trading platform operated by OTC Markets Group Inc. and is designed for early-stage and growth companies. Companies quoted on the OTCQB are required to meet ongoing financial reporting and disclosure requirements, including annual verification and management certification. Real-time quotes and market information for GreenLight are available on the OTC Markets website at www.otcmarkets.com.

GreenLight Metals Inc. is a Wisconsin-focused exploration company advancing copper-gold and gold projects across the Penokean Volcanic Belt and the Kalium Canyon epithermal gold project in Nevada’s Walker Lane. In Wisconsin, its portfolio includes the Bend copper-gold deposit, the Reef high-grade gold project, and the Lobo and Lobo East massive sulfide targets.

Matt Filgate, President & CEO, can be contacted at (778) 679-3579 or matt@greenlightmetals.com.

Source: GreenLight Metals Inc.

×

Welcome!

Biotech Reporter is the source most up-to-date real-time, direct-from-source News Tips and Story Leads.

By Subscribing you will receive Daily Biotech Update each day at 9:30 am ET (Market Open) in your inbox and you can unsubscribe any time.